Product Details
Tivicay 50mg Tablets#
Dolutegravir (Dolutegravir Sodium)50 mg
Tablet
ROA
Oral
Applicant Name
Glaxo Smithkline Consumer Nigeria PLC
NRN
B4-5134
Status
Active
Composition
ATC Code
J05AJ03
Product Category
Drugs
Marketing Category
Prescription-only Medicine (POM)
Packsize
1 X 30
Product Description
90 RNW-PP-121333 Tivicay 50mg Tablets DOLUTEGRAVIR (AS DOLUTEGRAVIR SODIUM) 50MG Dolutegravir sodium - 52.6mg) (Excipients - D-mannitol {E421} - q.s. {to 145.4}mg, Microcrystalline Cellulose {E460} - 60.0mg, Povidone K29/32 {E1201} - 15.0mg, Sodium starch Glycolate - 21.0mg, Sodium stearyl Fumarate {E365} - 6.0mg, Opadry II Yellow 85F92461 - 9.0mg, Purified water - q.s.) B4-5134 Drugs Imported Products 1*30 Prescription Only Medicine (POM) 3/24/2020 GLAXOSMITHKLINE PHARMACEUTICAL NIGERIA LIMITED, 1, Industrial Avenue, Ilupeju 12711000 regulatorypharma-ng@gsk.com Glaxo Operations UK Ltd (trading as Glaxo Wellcome Operations), Priory Street Ware Hertfordshire SG12 0DJ UK, United Kingdom
Manufacturer Name
Glaxo Operations UK Limited
Manufacturer Country
UNITED KINGDOM
Approval Date
2023-07-06
Expiry Date
2028-07-05